Procavea Biotech AG

Procavea Biotech is on a mission to transform RNA therapeutic delivery with its groundbreaking OP platform: a first-of-its-kind, nonviral protein cage designed for efficient siRNA transport. By tackling the limitations of current delivery technologies, we aspire to unlock the full potential of siRNA-based drugs, expanding their reach into diseases that could benefit from this powerful therapeutic modality.